Kardigan
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · New Jersey, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
506 Carnegie Ctr Ste 201, Princeton, New...Phone Number
(415) 573-3220Website
kardigan.bioRevenue
-Industry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
2
2
1
About Kardigan
Kardigan is a patient-driven heart health company that is modernizing cardiovascular drug development to deliver medicines that move patients beyond symptom management to functional cures. By matching critical disease drivers with treatment responders identified in clinical trials, Kardigan is developing a portfolio of medicines that modify the underlying cardiovascular disease pathophysiology to get patients closer to the cures they deserve.Explore more
Kardigan Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kardigan your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Kardigan is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Kardigan recently announced quarterly report
Product Launch: Get notified when Kardigan launches new products
Funding: Get notified immidiatlly once Kardigan has new funding data
Kardigan, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Kardigan had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Kardigan
Check if Kardigan has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Kardigan as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Kardigan is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Kardigan is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kardigan.
Kardigan financials insights
Gather financial insights about Kardigan, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$300M
Series B
$254M
Kardigan Tech Stack
A closer look at the technologies used by Kardigan
Most Recent Scoops
Person-Based
Stake & Stock Ownership, Finance
Person-Based
IPO, Finance
Person-Based
Events
Initial Public Offering (IPO)
IPO, Finance
New Hire
Executive Move
Executive Moves, New Hire
Kardigan News & Media
Heart drug biotech Kardigan raises $400m in upscaled IPO - pharmaphorum
Cardiovascular drug developer Kardigan has completed its IPO, raising substantially more than it originally anticipated.Office updates: Kardigan inks Princeton lease following $300M raise - NJBIZ
JLL helped the biopharma secure space to establish its East Coast presence, one of several recent transactions in the sector bringing tenants to Monmouth, Somerset and Morris counties.Kardigan Acquires Prolaio
Kardigan, a San Francisco, CA- and Princeton, NJ-based health company modernizing cardiovascular (CV) drug development, acquired Prolaio, a Chicago, IL-based clinical intelligence company advancing cardiology research and care with real-world patient data and insights. The amount of the deal was not disclosed. With the acquisition, Kardigan will gain access to Prolaio’s CV data collection and analytics […] The post Kardigan Acquires Prolaio appeared first on FinSMEs.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Kardigan
Sign Up For FreeTo access detailed company insights
Kardigan is a patient-driven heart health company that is modernizing cardiovascular drug development to deliver medicines that move patients beyond symptom management to functional cures. By matching critical disease drivers with treatment responders identified in clinical trials, Kardigan is developing a portfolio of medicines that modify the und... Read More
